Article Information
History
- May 11, 2022.
Article Versions
- Version 1 (January 10, 2022 - 01:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yi Ju1,2,3,*,
- Wen Shi Lee1,
- Emily H. Pilkington1,4,
- Hannah G. Kelly1,
- Shiyao Li3,
- Kevin J. Selva1,
- Kathleen M. Wragg1,
- Kanta Subbarao1,5,
- Thi H.O. Nguyen1,
- Louise C. Rowntree1,
- Lilith F. Allen1,
- Katherine Bond6,
- Deborah A. Williamson1,6,
- Nghia P. Truong1,4,
- Magdalena Plebanski2,
- Katherine Kedzierska1,
- Siddhartha Mahanty7,
- Amy W. Chung1,
- Frank Caruso3,
- Adam K. Wheatley1,
- Jennifer A. Juno1 and
- Stephen J. Kent1,8,*
- 1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC 3000, Australia
- 2School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia
- 3Department of Chemical Engineering, The University of Melbourne, Melbourne, VIC 3000, Australia
- 4Department of Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC 3000, Australia
- 5WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
- 6Department of Microbiology, Royal Melbourne Hospital, Melbourne, VIC 3000, Australia
- 7Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC 3000, Australia
- 8Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC 3000, Australia
- ↵*Corresponding authors. E-mail: david.ju{at}rmit.edu.au; skent{at}unimelb.edu.au
Posted May 11, 2022.
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
